3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
5
Breast
2
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Endometrial Neoplasms
15
Ovarian Neoplasms
5
Uterine Cervical Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Breast Neoplasms
4
Endometrial Hyperplasia
3
Pancreatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Interventions
Magnetic Resonance Spectroscopy
3
Fluorodeoxyglucose F18
3
pembrolizumab
2
Radiosurgery
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
FAPI-46
2
tipifarnib
1
sodium thiosulfate
1
sargramostim
1
regorafenib
1
montelukast
1
entrectinib
1
entinostat
1
cediranib
1
cc-486
1
carboxyamido-triazole
1
alectinib
1
aflibercept
1
Trastuzumab
1
Thiotepa
1
Tablets
1
Specimen Handling
1
Sirolimus
1
Sevoflurane
1
Ritonavir
1
Restraint, Physical
1
Radiotherapy
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Metformin
×
Gynecologic
×
Clear all
NCT02201381
2022-07-18
METRICS
Health Clinics Limited
Phase 3
Withdrawn